Literature DB >> 4979390

The chick embryo neutralization test in the assay of meningococcal antibody. 1. Infection of the embryo with Neisseria meningitidis.

K Ueda, B B Diena, L Greenberg.   

Abstract

Present methods of controlling meningococcal cerebrospinal meningitis have failed to contain the disease. This has led to the search for effective vaccines and to the development of methods for assaying the potency of these vaccines, as well as for measuring the immune response of the individual. The feasibility of using the sero-protection test in embryonated eggs for the assay of meningococcal antibody has been investigated. The paper describes detailed investigations of the infectious process established by injecting Neisseria meningitidis by various challenge routes. Embryos, even 10-12 days old, showed high susceptibility to meningococci injected via the yolksac or chorioallantoic vein, and lesser susceptibility when injected via the intra-allantoic and chorioallantoic routes. The deaths of intravenously inoculated embryos coincided with the multiplication of the organisms and ensuing septicaemia. A study of the infection in embryos which had died, or were killed, 18-24 hours after inoculation showed a specific localization of the organisms in the brain.

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 4979390      PMCID: PMC2554608     

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  4 in total

1.  Studies on immunity in meningococal meningitis.

Authors:  N A Vedros; D H Hunter; J H Rust
Journal:  Mil Med       Date:  1966-11       Impact factor: 1.437

2.  Meningococcal infections--the military and the civilians.

Authors:  H A Feldman
Journal:  Ann Intern Med       Date:  1966-11       Impact factor: 25.391

3.  A somatic antigen vaccine for the prevention of meningococcal cerebrospinal meningitis.

Authors:  L Greenberg; M Y Cooper
Journal:  Bull World Health Organ       Date:  1965       Impact factor: 9.408

4.  EXPERIMENTAL MENINGOCOCCUS INFECTION OF THE CHICK EMBRYO.

Authors:  G J Buddingh; A D Polk
Journal:  J Exp Med       Date:  1939-10-31       Impact factor: 14.307

  4 in total
  5 in total

Review 1.  The meningococcus and mechanisms of pathogenicity.

Authors:  I W DeVoe
Journal:  Microbiol Rev       Date:  1982-06

2.  Protection against group B meningococcal disease: evaluation of serotype 2 protein vaccines in a mouse bacteremia model.

Authors:  D E Craven; C E Frasch
Journal:  Infect Immun       Date:  1979-10       Impact factor: 3.441

3.  The chick embryo neutralization test in the assay of meningococcal antibody. 2. Response of the embryo to meningococcal endotoxin and to infection.

Authors:  K Ueda; B B Diena; H Sato; L Greenberg
Journal:  Bull World Health Organ       Date:  1969       Impact factor: 9.408

4.  Protection against group B meningococcal disease. II. Infection and resulting immunity in a guinea pig model.

Authors:  C E Frasch; J D Robbins
Journal:  J Exp Med       Date:  1978-03-01       Impact factor: 14.307

5.  Protection against group B meningococcal disease. I. Comparison of group-specific and type-specific protection in the chick embryo model.

Authors:  C E Frasch; L Parkes; R M McNelis; E C Gotschlich
Journal:  J Exp Med       Date:  1976-08-01       Impact factor: 14.307

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.